Published in J Am Soc Nephrol on November 01, 2001
The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol (2013) 2.06
Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States. Clin J Am Soc Nephrol (2009) 1.59
Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol (2008) 1.44
C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial. Clin J Am Soc Nephrol (2008) 1.34
Racial disparities in renal replacement therapy. J Natl Med Assoc (2002) 1.15
Association of ESA hypo-responsiveness and haemoglobin variability with mortality in haemodialysis patients. Nephrol Dial Transplant (2010) 0.99
Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol (2011) 0.95
Hematocrit compensation in electrochemical blood glucose monitoring systems. J Diabetes Sci Technol (2012) 0.95
Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data. Clin J Am Soc Nephrol (2009) 0.92
Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. Int Urol Nephrol (2011) 0.90
Clinical factors and the decision to transfuse chronic dialysis patients. Clin J Am Soc Nephrol (2013) 0.90
Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS. Nephrol Dial Transplant (2008) 0.89
Comparative effectiveness of two anemia management strategies for complex elderly dialysis patients. Med Care (2014) 0.87
Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol (2014) 0.86
Negative trials in nephrology: what can we learn? Kidney Int (2008) 0.84
Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experience. NDT Plus (2011) 0.81
Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients. Kidney Res Clin Pract (2015) 0.81
Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant (2013) 0.80
Role of folate deficiency on erythropoietin resistance in pediatric and adolescent patients on chronic dialysis. Pediatr Nephrol (2005) 0.80
The effect of altitude change on anemia treatment response in hemodialysis patients. Am J Epidemiol (2011) 0.79
Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide. Int J Nanomedicine (2013) 0.78
Recombinant human epoetin beta in the treatment of renal anemia. Ther Clin Risk Manag (2007) 0.78
Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series. BMC Nephrol (2013) 0.78
Clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. Pan Afr Med J (2014) 0.77
Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study. BMC Nephrol (2012) 0.77
[Predictors of response to the CERA in chronic hemodialysis treatment-naive by erythropoiesis-stimulating agent]. Pan Afr Med J (2015) 0.77
The impact of hyporesponsiveness to erythropoietin-stimulating agents on time-dependent mortality risk among CKD stage 5D patients: a single-center cohort study. Clin Exp Nephrol (2012) 0.77
Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis. BMC Nephrol (2011) 0.76
Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis. Ther Clin Risk Manag (2009) 0.76
What are the considerations in balancing benefits and risks in Iron treatment?: Balancing Benefits and Safety with Intravenous Iron Treatment. Semin Dial (2016) 0.75
Anemia: To TREAT or not to TREAT--that is the question. Nat Rev Nephrol (2010) 0.75
Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis. Clinics (Sao Paulo) (2014) 0.75
Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study. BMC Nephrol (2017) 0.75
Anemia management trends in patients on peritoneal dialysis in the past 10 years. Int J Clin Exp Med (2015) 0.75
Treatment of renal anemia: Erythropoiesis stimulating agents and beyond. Kidney Res Clin Pract (2017) 0.75
Safety of intravenous iron in hemodialysis patients. Hemodial Int (2017) 0.75
SH2 domains recognize specific phosphopeptide sequences. Cell (1993) 17.28
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med (1994) 7.25
Variations in resource utilization among medical specialties and systems of care. Results from the medical outcomes study. JAMA (1992) 6.88
Assembly and analysis of conical models for the HIV-1 core. Science (1999) 6.35
Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med (1999) 6.27
MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity (1997) 5.23
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J (1998) 4.46
Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature (1993) 4.33
Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem (1997) 4.12
Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet (1994) 4.12
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature (1999) 3.99
Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol (1993) 3.99
Visual acuity and quality of life in patients with cataract in Doumen County, China. Ophthalmology (1999) 3.82
Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem (1997) 3.80
Cognitive impairment in hemodialysis patients is common. Neurology (2006) 3.68
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med (1998) 3.59
A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem (1995) 3.54
Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science (1999) 3.47
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet (2004) 3.45
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess (2007) 3.43
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol (2004) 3.29
Solution structure of Ca(2+)-calmodulin reveals flexible hand-like properties of its domains. Nat Struct Biol (2001) 3.18
Active cascade testing for carriers of cystic fibrosis gene. BMJ (1994) 3.10
The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase. Nature (1989) 3.09
Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate. Nature (1989) 3.07
A splicing-dependent regulatory mechanism that detects translation signals. EMBO J (1996) 3.07
Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem (1996) 3.05
SAR and B1 field distributions in a heterogeneous human head model within a birdcage coil. Specific energy absorption rate. Magn Reson Med (1998) 2.92
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer. J Natl Cancer Inst (2001) 2.88
Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation. Biochem J (1987) 2.84
Positional cloning of the mouse saccharin preference (Sac) locus. Chem Senses (2001) 2.75
Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension (1998) 2.59
Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc Natl Acad Sci U S A (2001) 2.58
Concordant evolution of a symbiont with its host insect species: molecular phylogeny of genus Glossina and its bacteriome-associated endosymbiont, Wigglesworthia glossinidia. J Mol Evol (1999) 2.58
Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J Biol Chem (1999) 2.51
Asymmetric mitotic segregation of the yeast spindle pole body. Cell (1992) 2.46
A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis (1998) 2.42
Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol Cell Biol (2001) 2.39
Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun (2010) 2.38
Immune response in Stat2 knockout mice. Immunity (2000) 2.37
Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol (2001) 2.35
Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev (1996) 2.32
Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature (1994) 2.29
The Alzheimer's peptide a beta adopts a collapsed coil structure in water. J Struct Biol (2000) 2.26
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Protective factors against suicidal acts in major depression: reasons for living. Am J Psychiatry (2000) 2.17
Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet (1999) 2.12
Spatial variation of T2 in human articular cartilage. Radiology (1997) 2.12
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int (2001) 2.06
Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol (1999) 2.04
Clinical teaching: maintaining an educational role for doctors in the new health care environment. Med Educ (2000) 2.03
Polymorphisms in the taste receptor gene (Tas1r3) region are associated with saccharin preference in 30 mouse strains. J Neurosci (2004) 2.03
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation (1997) 2.03
Deletion of PrBP/delta impedes transport of GRK1 and PDE6 catalytic subunits to photoreceptor outer segments. Proc Natl Acad Sci U S A (2007) 2.02
DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology (1998) 2.02
The recovery of cognitive function after general anesthesia in elderly patients: a comparison of desflurane and sevoflurane. Anesth Analg (2001) 1.92
Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol Cell (2000) 1.91
Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet (2000) 1.90
Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J Immunol (1994) 1.90
The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene (2000) 1.89
Age interacts with heaviness of smoking in predicting success in cessation of smoking. Am J Epidemiol (1992) 1.88
CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol (1998) 1.85
DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics (2001) 1.85
Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials (1995) 1.83
A selective defect in IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon. EMBO J (1993) 1.82
Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV. Virology (1998) 1.82
Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care (1999) 1.82
The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther (1999) 1.81
The economic burden of Campylobacter-associated Guillain-Barré syndrome. J Infect Dis (1997) 1.81
A genome-wide analysis of Arabidopsis Rop-interactive CRIB motif-containing proteins that act as Rop GTPase targets. Plant Cell (2001) 1.80
Dislodgment of polyethylene liners in first and second-generation Harris-Galante acetabular components. A report of eighteen cases. J Bone Joint Surg Am (2001) 1.78
The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol Cell Biol (1996) 1.77
Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77
Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views. Health Technol Assess (2000) 1.74
Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem (1999) 1.73
A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol (1996) 1.73
Precursor RNAs harboring nonsense codons accumulate near the site of transcription. Mol Cell (2001) 1.72
Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther (2001) 1.71
Demographic and psychosocial predictors of fruit and vegetable intakes differ: implications for dietary interventions. J Am Diet Assoc (1998) 1.70
Economic costs and trade impacts of microbial foodborne illness. World Health Stat Q (1997) 1.70
Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis (1999) 1.68
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res (2001) 1.68
Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet (1997) 1.68
Raf-1: a kinase currently without a cause but not lacking in effects. Cell (1991) 1.68
Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci U S A (1997) 1.67
Measurement of orientation and distribution of cellular alignment and cytoskeletal organization. Ann Biomed Eng (2000) 1.67
Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol (2000) 1.66
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood (2001) 1.66
The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey. Obes Rev (2012) 1.66
Up-converting phosphor reporters for nucleic acid microarrays. Nat Biotechnol (2001) 1.65
Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjug Chem (2001) 1.65
Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer (2001) 1.62
Models for improving cataract surgical rates in southern China. Br J Ophthalmol (2002) 1.61
Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates. Radiology (1995) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Cardiovascular disease after renal transplantation. J Am Soc Nephrol (1996) 1.58
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol (2008) 1.58
Effects of antihypertensive therapy on serum lipids. Ann Intern Med (1995) 1.57
Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res (1996) 1.57